2019年3期
刊物介紹
本刊主要是及時(shí)報(bào)道我國(guó)在腫瘤防治研究領(lǐng)域包括癌癥基礎(chǔ)理論研究和癌癥預(yù)防、臨床治療研究方面的新進(jìn)展、新成果，內(nèi)容涉及腫瘤病因?qū)W與滸病學(xué)，實(shí)驗(yàn)?zāi)[瘤學(xué)、腫瘤細(xì)胞分子生物學(xué)，腫瘤病理學(xué)以及腫瘤影像診斷、腫瘤外科治療、化學(xué)治療、放射治療、介入治療、生物治療和中西醫(yī)結(jié)合治療腫瘤等各分支學(xué)科，旨在促進(jìn)國(guó)內(nèi)外學(xué)術(shù)交流，提高我國(guó)癌癥研究與癌癥治療水平。
Chinese Journal of Cancer Research
- Management guidelines for primary lung cancer 2018: Chinese standards in clinical practice
- Management guidelines for esophageal carcinoma 2018: Chinese standards in clinical practice
- Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018
- Incidence and mortality of esophagus cancer in China, 2008-2012
- Incidence and mortality of corpus uteri cancer in China,2008-2012
- A comparison of short-term postoperative outcomes including nutritional status between gastrectomy with simultaneous cholecystectomy and gastrectomy only in patients with gastric cancer
- Predictive values of multidetector-row computed tomography combined with serum tumor biomarkers in preoperative lymph node metastasis of gastric cancer
- Immune signature profiling identified prognostic factors for gastric cancer
- Correlation of radiotherapy with prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping
- Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study
- Burden of colorectal cancer in China, 1990-2017: Findings from the Global Burden of Disease Study 2017
- Cancer IgG, a potential prognostic marker, promotes colorectal cancer progression
- Adjuvant hormone therapy after radical prostatectomy in highrisk localized and locally advanced prostate cancer: First multicenter, observational study in China
- Hexokinase II promotes the Warburg effect by phosphorylating alpha subunit of pyruvate dehydrogenase
- Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis
- Prognostic significance of periostin in colorectal cancer